Skip to content

Factors associated with early death among children and adolescents with cancer in Brazil: a nationwide registry-based study

Sep 2026 · Pediatric Hematology & Oncology · Vol 43, pp. 429 - 444 · 0 citations · 50 references
Medicine

TL;DR

Early death among pediatric cancer patients in Brazil is strongly influenced by tumor type and marked social, regional, and informational disparities.

Abstract

Abstract This study aimed to identify sociodemographic, clinical, and care-related factors associated with early death in childhood and adolescent cancer patients in Brazil. A retrospective cohort study was conducted using data from the Brazilian Hospital Cancer Registry Integrator Database (IntegradorRHC). All cancer cases diagnosed in individuals aged 0–19 years between 2000 and 2023 were included. Early death was defined as death at the end of the first treatment or within 12 months after diagnosis. Associations were assessed using multivariable logistic regression, and results were expressed as adjusted odds ratios (aOR) with 95% confidence intervals (CI). Among 102,430 eligible cases, early death occurred in 24.7%. Increased risk of early death was independently associated with older age at diagnosis (aOR = 1.006), non-white race/skin color (aOR = 1.467), missing information on race/skin color (aOR = 3.177), unknown referral origin (aOR = 3.507), residence in the Southeast region (aOR = 1.921), and receipt of chemotherapy (aOR = 1.624). Central nervous system tumors (aOR = 2.430), soft tissue sarcomas, bone tumors, and leukemias showed the highest risk of early death. Surgery (aOR = 0.636) and radiotherapy (aOR = 0.750) were associated with reduced risk, while lymphomas (aOR =0.70) showed a protective association. Early death among pediatric cancer patients in Brazil is strongly influenced by tumor type and marked social, regional, and informational disparities.

View source

Similar papers

Open access Sep 2026

Survival of adolescent and young adult cancer patients in North Malabar: A hospital-based cancer registry data

It is indicated that AYA cancer patients are more female (61%) than male (39%), and breast cancer was the leading cancer among females (38.3%) in this study, underscoring the significant progress achieved in early detection and treatment.

Bindu Therayangalath, Saina Sunilkumar, Satheesan Balasubramanian · 0 citations
Open access Aug 2026

Childhood cancer incidence, survival and mortality patterns in Argentina, 2000–2022: from the Argentine Oncopediatric Registry (ROHA)

The Argentina Oncopediatric Registry (ROHA), established in 2000, provides a unique framework for evaluating long-term trends in childhood cancer incidence, survival, and mortality and offers a model to improve equity, quality of care, and outcomes in Argentina.

Florencia Moreno, M. Chaplin, Mariana Nana et al. · 0 citations
Oct 2026

International patterns and incidence trends of lung cancer in adolescent and young adults by histological subtype and sex.

BACKGROUND Lung cancer in adolescents and young adults (AYAs) presents distinct features compared to older populations. METHODS This population-based study utilized GLOBOCAN 2022 data to estimate lung cancer age-standardized incidence rates (ASIR) and mortality rates (ASMR) in individuals aged 15-39 years across 185...

Ke Liu, Wei-Tao Su, W. Shu et al. · 0 citations
Open access Oct 2026

Impact of Neighborhood Socioeconomic Status on Presentation and Treatment of Thyroid Cancer.

OBJECTIVE We examined associations between multilevel sociodemographic factors and extent of disease at presentation and time to treatment in patients with differentiated thyroid cancer (DTC). STUDY DESIGN Population-based study. SETTING California Cancer Registry (CCR). METHODS All adults diagnosed with DTC in C...

Nazineen Kandahari, Mindy C. Derouen, Stephen Li et al. · 0 citations
Open access Sep 2026

Male Breast Cancer in Brazil: Epidemiology, Disparities, and Mortality Trends.

PURPOSE Male breast cancer (mBC) is a rare neoplasm, accounting for < 1% of breast cancers and approximately 1% of male tumors worldwide. Evidence regarding its epidemiology and clinical management in Brazil is limited. This study aimed to analyze epidemiologic and clinical data on mBC in Brazil. MATERIALS AND METHOD...

F. Brandão, Martina Parenza Arenhardt, Gabriela Brito Bothrel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.